Financial statements Vulm Biotechnology

Balance sheet of Vulm Biotechnology

Company age:
Age:
13 y. 1 m. 30 d.
Share capital:
Share capital:
6 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of VULM BIOTECHNOLOGY

Year
2018
2019
Total assets 547 053,74 438 014,76
A. Fixed assets 199 676,32 154 648,60
B. Current assets 347 377,42 283 366,16
C. Share capital contributions (basic funds) 0,00 0,00
D. Own shares (stocks) 0,00 0,00
Total liabilities 547 053,74 438 014,76
A. Equity 75 977,20 82 200,24
B. Liabilities and provisions for liabilities 471 076,54 355 814,52
I. Long-term liabilities 106 255,53 106 255,53
II. Short-term liabilities 364 821,01 249 558,99
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.